The Monday 13 June at 2:30 pm at Fasken Martineau, located at the Bourse Tower, the CTS event will take place and will gather companies, investors and partners from medical technologies sector.
The CTS, which is focus on the commercial development of innovating companies in the medical technologies sector in Quebec, achieved a new step thanks to the partnership signed last November with Desjardins-Innovatech.
At the present time, 7 financial and accompaniment arrangements have been assign, which attract a constant rising number of companies who wants to take part in the trusted and dynamic CTS program.
Associated with the finance, coaching, analyses and listening, allowing companies to have a mature strategic reflexion to be able to conquer new market share.
Thanks to this positive experience along with the CTS, Éric Moreau, Indalo President explained: « The collaboration with the CTS is effective and trainer. They know the right questions to mature projects and accelerate to the next level. The flexible support structure to quickly meet all the challenges that a startup company can live. Real team players! »
That’s why the CTS gathers companies, investors and partners of entrepreneurship at the: « Medical technologies meeting: At the heart of the Quebecers’ ecosystem. »
- The need of a complete market survey and a perfect knowledge of its potential clients in order to develop the commercialisation, will be explain.
- The CTS formula, which link an economic fabric of different actors, will be detailed.
- The companies who have been in the CTS program will explain their experiences and the generated benefits.
The CTS collaborators will be there and available for all the participants all along the event to discuss around the medical technologies sector.
The participants could also talk about the collaboration’s high value that push up the new technologies development.
Due to the meeting, the participants will have the opportunity to understand what type of ressources must be implement for the promotion and development of the medical technologic innovation in Quebec.